Address correspondence to Thomas F. Wierzba, US NAMRU2, 4540 Phnom Penh Place, Dulles, VA 20189. E-mail:
Authors’ addresses: Thomas F. Wierzba, U.S. Naval Medical Research Unit No. 2, 4540 Phnom Penh Place, Dulles, VA 20189, Tel: 855-23-884228 (Phnom Penh), Fax: 855-23-883-561, E-mail:
Acknowledgments: The authors thank the Surveillance Medical Officers of the WHO in Nepal for their efforts to develop JE surveillance during difficult times. We also thank Mahendra Bahadur Bista, the Director General and Director of the Epidemiology and Disease Control Division, Shyam Raj Upreti, Chief of the National Immunization Program, and Mr. Shyam P Khanal, Medical Technologist, National Public Health Laboratory of Nepal for their cooperation.
Disclaimer: The opinions and assertions contained herein are not to be construed as official or as reflecting the views of the U.S. government or the U.S. Department of Defense.
Financial support: Financial support was provided by the United States Agency for International Development.
Bista MB, Banerjee MK, Shin SH, Tandan JB, Kim MH, Sohn YM, Ohrr HC, Tang JL, Halstead SB, 2001. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358 :791–795.
Tandan JB, Ohrr H, Sohn YM, Yoksan S, Ji M, Nam CM, Hal-stead SB, 2007. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 25 :5041–5045.
WHO, 2003. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: World Health Organization.
Burke DS, Nisalak A, 1982. Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol 15 :353–361.
Burke DS, Nisalak A, Ussery MA, 1982. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. J Clin Microbiol 16 :1034–1042.
Ohrr H, Tandan JB, Sohn YM, Shin SH, Pradhan DP, Halstead SB, 2005. Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet 366 :1375–1378.
Akiba T, Osaka K, Tang S, Nakayama M, Yamamoto A, Kurane I, Okabe N, Umenai T, 2001. Analysis of Japanese encephalitis epidemic in Western Nepal in 1997. Epidemiol Infect 126 :81–88.
Zimmerman MD, Scott RM, Vaughn DW, Rajbhandari S, Nisalak A, Shrestha MP, 1997. Short report: an outbreak of Japanese encephalitis in Kathmandu, Nepal. Am J Trop Med Hyg 57 :283–284.
Basnyat B, Zimmerman MD, Shrestha Y, Scott RM, Endy TP, 2001. Persistent Japanese encephalitis in Kathmandu: the need for immunization. J Travel Med 8 :270–271.
Chatterjee S, Chattopadhyay D, Bhattacharya MK, Mukherjee B, 2004. Serosurveillance for Japanese encephalitis in children in several districts of West Bengal, India. Acta Paediatr 93 :390–393.
Kumar R, Tripathi P, Singh S, Bannerji G, 2006. Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India. Clin Infect Dis 43 :123–131.
Kari K, Liu W, Gautama K, Mammen MP Jr, Clemens JD, Nisalak A, Subrata K, Kim HK, Xu ZY, 2006. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med 4 :8.